Sepideh Taghizad, Khadijeh Behbahaninia, M. Jahromy, A. Davood
{"title":"吡咯吡啶和异吲哚作为潜在的抗惊厥剂:设计、合成和药理学评价。","authors":"Sepideh Taghizad, Khadijeh Behbahaninia, M. Jahromy, A. Davood","doi":"10.2174/1573409918666220512000247","DOIUrl":null,"url":null,"abstract":"BACKGROUND AND OBJECTIVE\nPhthalimide as the rigid form of ameltolide exhibits a phenytoin-like profile of drug-receptor interaction and is active in the MES model and inactive in the PTZ model as anti-epileptic agent. In this research, based on the isosteric replacement, we have reported the design, preparation, and antiepileptic activity of 13 new analogs of pyrrolopyridine and isoindole.\n\n\nMETHODS\nThe designed compounds were prepared by condensing 3, 4-pyridine dicarboxylic anhydride or 4-fluorophthalic anhydride with different respective aryl amines. MES and PTZ induced seizure models were done to evaluate the antiepileptic effect of the prepared ligands.\n\n\nRESULTS\nThe prepared ligands have significantly affect both tonic and clonic seizures. In tonic seizures, the prepared compounds decrease mortality to a significant extent and in clonic seizures showed better frequency and latency significantly. Compounds 9, 12 and 13 were the most potent ligands that were more potent than phenytoin.\n\n\nCONCLUSION\nIt is concluded that the best distance between two aryl parts is two bonds and the substitution of the nitro group at the meta position of the phenyl ring is better than para position. Our research group has been investigating this concept for designing newer compounds with better anticonvulsant activity.","PeriodicalId":10886,"journal":{"name":"Current computer-aided drug design","volume":"28 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Pyrrolopyridine and Isoindole as potential anticonvulsant agents: Design, synthesis and pharmacological evaluation.\",\"authors\":\"Sepideh Taghizad, Khadijeh Behbahaninia, M. Jahromy, A. Davood\",\"doi\":\"10.2174/1573409918666220512000247\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND AND OBJECTIVE\\nPhthalimide as the rigid form of ameltolide exhibits a phenytoin-like profile of drug-receptor interaction and is active in the MES model and inactive in the PTZ model as anti-epileptic agent. In this research, based on the isosteric replacement, we have reported the design, preparation, and antiepileptic activity of 13 new analogs of pyrrolopyridine and isoindole.\\n\\n\\nMETHODS\\nThe designed compounds were prepared by condensing 3, 4-pyridine dicarboxylic anhydride or 4-fluorophthalic anhydride with different respective aryl amines. MES and PTZ induced seizure models were done to evaluate the antiepileptic effect of the prepared ligands.\\n\\n\\nRESULTS\\nThe prepared ligands have significantly affect both tonic and clonic seizures. In tonic seizures, the prepared compounds decrease mortality to a significant extent and in clonic seizures showed better frequency and latency significantly. Compounds 9, 12 and 13 were the most potent ligands that were more potent than phenytoin.\\n\\n\\nCONCLUSION\\nIt is concluded that the best distance between two aryl parts is two bonds and the substitution of the nitro group at the meta position of the phenyl ring is better than para position. Our research group has been investigating this concept for designing newer compounds with better anticonvulsant activity.\",\"PeriodicalId\":10886,\"journal\":{\"name\":\"Current computer-aided drug design\",\"volume\":\"28 1\",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-05-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current computer-aided drug design\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/1573409918666220512000247\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current computer-aided drug design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1573409918666220512000247","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Pyrrolopyridine and Isoindole as potential anticonvulsant agents: Design, synthesis and pharmacological evaluation.
BACKGROUND AND OBJECTIVE
Phthalimide as the rigid form of ameltolide exhibits a phenytoin-like profile of drug-receptor interaction and is active in the MES model and inactive in the PTZ model as anti-epileptic agent. In this research, based on the isosteric replacement, we have reported the design, preparation, and antiepileptic activity of 13 new analogs of pyrrolopyridine and isoindole.
METHODS
The designed compounds were prepared by condensing 3, 4-pyridine dicarboxylic anhydride or 4-fluorophthalic anhydride with different respective aryl amines. MES and PTZ induced seizure models were done to evaluate the antiepileptic effect of the prepared ligands.
RESULTS
The prepared ligands have significantly affect both tonic and clonic seizures. In tonic seizures, the prepared compounds decrease mortality to a significant extent and in clonic seizures showed better frequency and latency significantly. Compounds 9, 12 and 13 were the most potent ligands that were more potent than phenytoin.
CONCLUSION
It is concluded that the best distance between two aryl parts is two bonds and the substitution of the nitro group at the meta position of the phenyl ring is better than para position. Our research group has been investigating this concept for designing newer compounds with better anticonvulsant activity.
期刊介绍:
Aims & Scope
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.
Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.